Terms: = Endocrine gland cancer AND SERPINE1, PAI, PAI-1, PAI1, PLANH1 AND Staging
5 results:
1. Using The cancer Genome Atlas data to refine the 8th edition of the American Joint Committee on cancer staging for papillary thyroid carcinoma.
Poma AM; Macerola E; Torregrossa L; Elisei R; Santini F; Basolo F
Endocrine; 2021 Apr; 72(1):140-146. PubMed ID: 32915437
[TBL] [Abstract] [Full Text] [Related]
2. Presentation, disease progression and outcomes of adrenal gland metastases.
Mao JJ; Dages KN; Suresh M; Bancos I
Clin Endocrinol (Oxf); 2020 Nov; 93(5):546-554. PubMed ID: 32569405
[TBL] [Abstract] [Full Text] [Related]
3. Expression, Intracellular Localization, and Prognostic Value of Plasminogen Activator Inhibitor 1 and pai-1 RNA-Binding Protein 1 in Primary and Recurrent Ovarian cancer: A Study of the Tumor Bank Ovarian cancer Network.
Koensgen D; Stope MB; Tuerbachova I; Bruennert D; Kohlmann T; Braicu I; Sehouli J; Denkert C; Darb-Esfahani S; Stickeler E; Sofroni D; Dahl E; Mustea A
Gynecol Obstet Invest; 2018; 83(5):508-514. PubMed ID: 28738361
[TBL] [Abstract] [Full Text] [Related]
4. Analysis of potential prognostic factors in 111 patients with ovarian cancer.
Hornung R; Urs E; Serenella E; Edward W; Ursula S; Urs H; Daniel F
Cancer Lett; 2004 Mar; 206(1):97-106. PubMed ID: 15019165
[TBL] [Abstract] [Full Text] [Related]
5. Clinical value of components of the plasminogen activation system in ovarian cyst fluid.
Boss EA; Massuger LF; Thomas CM; Geurts-Moespot A; van Schaik JH; Boonstra H; Sweep CG
Anticancer Res; 2002; 22(1A):275-82. PubMed ID: 12017303
[TBL] [Abstract] [Full Text] [Related]
